The assessment and correction of nutritional deficiencies in patients is essential to patient management, however not the only assessment that needs to be addressed.
Urinary neuro-biogenic amines (Neurotransmitter testing) provide insight into a patient’s overall ability to synthesise and metabolise neurotransmitters. In this short webinar, Andrea Gruszecki ND, Client Consultant in the Scientific Support Department of Doctor’s Data, presents how the Neuro-Biogenic Amine Profile can help identify alterations in urinary neurotransmitter status which may be associated with a variety of conditions from metabolic to behavioral disorders.
What is covered:
- Review the evaluation of biogenic amine & neurotransmitter metabolism and the effects of dysfunction in synthesis or metabolism
- Review how toxic exposure,inheritance, and nutrition may affect enzyme functions and neurotransmission
- Review strategies for nutritional support of neurotransmitter synthesis and metabolism, as outlined in scientific literature
- Review strategies to diminish oxidative stress and neuroinflammation
Plus, a 20 minute recording of Q&A with Warren Maginn has been included as a follow on from this webinar.
Length: 40 minutes, plus 20 minutes of Q&A (60 minutes total)
Presenter: Andrea Guszecki
Q&A: Warren Maginn
Terms: This course is subject to future edits and alterations.
CPE Points: Please click here for more information.